NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
05/12/2026
Back to search
Official data from USPTO
VECTURA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
VECTURA
ST13
US500000098217245Class
5, 10, 40, 42
Filing
98217245
Registration
8248997
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
29
Latest update
05/12/2026
Trademark type
Word
Nice classes
5, 10, 40, 42
Filing date
10/10/2023
Registration date
05/12/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
05/12/2026
Last transaction
05/12/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Wiltshire, GB
Examiner
PERRY, KIMBERLY B
Law office
M30
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Vectura Limited
Representatives
Molly B. Markley YOUNG, BASILE, HANLON & MACFARLANE P.C.
Technical classification
Nice Classes
Class 5Class 10Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory system; pharmaceutical and veterinary preparations for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical and veterinary preparations for the alleviation or prevention of pain or inflammation; inhalers filled with powders for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynaecological conditions; pharmaceutical preparationspowders for asthma inhalers; pharmaceutical preparationspowders for transdermal injection for the alleviation or prevention of painfor the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for oral ingestion for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; pharmaceutical and veterinary preparations for topical administration for the treatment of diseases or conditions of the respiratory systemdiseases or conditions of the cardiovascular systemdiabetescancerarthritisdiseases or conditions of the gastro-intestinal systemdiseases or conditions of the central nervous systemdiseases or conditions of the endocrine systemdiseases or conditions of the genito-urinary systeminfectionsskin disorders and gynecological conditions; medicaments for inhalation therapy; pharmaceutical preparationspulmonary delivery compositions for use in facilitating the inhalation of pharmaceuticalsdrug delivery agents consisting of compounds that facilitate delivery by inhalation of a wide range of pharmaceuticals; medicaments for the treatment of erectile dysfunction; medicaments for the treatment of chronic obstructive pulmonary disease; medicaments for the treatment of premature ejaculation; medicaments for the treatment of cystic fibrosis; medicaments for the treatment of female sexual dysfunction; medicaments for the treatment of migraines; medicaments for the treatment of asthma; all of the above goods not for use in the dental field
Class 10
Surgicalmedicalveterinary apparatusinstruments and parts and fittings therefordrug delivery devices and parts and fittings therefordrug delivery systems being nebulizers for medical purposes; inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; active dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; passive dry powder inhalers sold empty for medical or therapeutic purposes and parts and fittings therefor; nebulisers for inhalation therapyrespiration therapyparts and fittings therefor; inhaler devices sold empty for medical or therapeutic purposes and parts and fittings therefor; all of the above goods not for use in the dental field
Class 40
Custom manufacture of pharmaceuticals; Consulting services in the field of pharmaceutical formulationdevelopment of medical applications for drugs and pharmaceutical formulationsdrug designdrug formulationpharmaceutical formulationdevelopment of pharmaceutical formulations
Class 42
Scientific research and technological servicesresearchdesignanalysistestingin the field of pharmaceuticals and drug delivery systemsdrug delivery systems and devices; Scientific research and technological servicesresearch in the field of medicine; industrial analysis and research services in the fields of drug delivery systems and devices; research services in the fields of medicine; pharmaceutical research services; pharmaceutical products development services; device and product safety testing services;
Publications
History of USPTO decisions and trademark events.
29 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
05/12/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/24/2026
PUBO
PUBLISHED FOR OPPOSITION
03/24/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/18/2026
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/27/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/23/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/19/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/22/2026
GNRT
NON-FINAL ACTION E-MAILED
01/22/2026
CNRT
NON-FINAL ACTION WRITTEN
01/22/2026
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
01/22/2026
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/16/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/08/2026
ATRV
ATTORNEY REVIEW COMPLETED
01/08/2026
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
04/21/2025
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
09/12/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/09/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/06/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/06/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/06/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
06/10/2024
GNRT
NON-FINAL ACTION E-MAILED
06/10/2024
CNRT
NON-FINAL ACTION WRITTEN
06/10/2024
DOCK
ASSIGNED TO EXAMINER
05/29/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/16/2023
NWAP
NEW APPLICATION ENTERED
10/13/2023
Continuous trademark protection
Get notified about every new filing that threatens VECTURA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.